Latest News and Press Releases

Rockville, MD, Sept. 24, 2024 (GLOBE NEWSWIRE) -- In its new study, Fact.MR states that the global cancer supportive care product market is estimated to reach a value of US$ 35.47 billion in 2024...

Wilmington, Delaware, United States, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global active pharmaceutical ingredients (API) market is projected to flourish at a CAGR...

Burlingame, April 10, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, Global Cancer supportive care products Market is estimated to be valued at US$ 32,458.0 million in 2023 and is...

Burlingame, Jan. 24, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, Global Cattle Healthcare Market is estimated to be valued at US$ 8,313.5 million in 2022 and is expected to...

Selbyville, Delaware, Oct. 11, 2022 (GLOBE NEWSWIRE) -- The lyophilized injectable drugs market value is projected to reach USD 740 billion by 2030, according to a new research report by Global...

New York, USA, Sept. 20, 2021 (GLOBE NEWSWIRE) -- A research report published by Research dive on the global home infusion therapy market explains the impact of COVID-19 pandemic on the current...

New York, USA, June 03, 2021 (GLOBE NEWSWIRE) -- According to a recent report by Research Dive, the global home infusion therapy market is anticipated to reach $49.5 billion by the end of 2026 at a...

YONKERS, N.Y. , April 21, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents...

NORTHVALE, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...

YONKERS, N.Y., Nov. 01, 2018 (GLOBE NEWSWIRE) --  ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody...